Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3501675015 | Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3501676019 | Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3681523016 | Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Is a | Acetaminophen compound preparation | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Is a | Product containing phenyltoloxamine (medicinal product) | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has active ingredient | Ethanolamine | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has active ingredient | Sedating antihistamine | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has active ingredient | Non-opioid analgesic (substance) | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has active ingredient | Phenyltoloxamine (substance) | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Is a | Product containing paracetamol and phenyltoloxamine citrate and salicylamide | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has active ingredient | Salicylamide | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has active ingredient | Cardiovascular agent (substance) | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Is a | Product containing paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has basis of strength substance (attribute) | Paracetamol | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength numerator value | 300 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has basis of strength substance (attribute) | Phenyltoloxamine citrate | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength numerator value | 20 (kwalificatiewaarde) | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has active ingredient | Salicylamide | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has basis of strength substance (attribute) | Salicylamide | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength numerator value | 200 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has basis of strength substance (attribute) | Phenyltoloxamine citrate | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength numerator value | 20 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has basis of strength substance (attribute) | Salicylamide | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength numerator value | 200 (kwalificatiewaarde) | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has basis of strength substance (attribute) | Paracetamol | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has presentation strength numerator value | 300 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has precise active ingredient | Salicylamide | false | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has precise active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has precise active ingredient | Paracetamol | false | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Is a | Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Count of base of active ingredient | 3 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Is a | Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has basis of strength substance (attribute) | Salicylamide | true | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has basis of strength substance (attribute) | Phenyltoloxamine citrate | true | Inferred relationship | Some | 1 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has precise active ingredient | Paracetamol | true | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has precise active ingredient | Salicylamide | true | Inferred relationship | Some | 2 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has basis of strength substance (attribute) | Paracetamol | true | Inferred relationship | Some | 3 | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Has precise active ingredient | Phenyltoloxamine citrate | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets